about
Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell linesRestoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosisRapid Folding and Unfolding of Apaf-1 CARDCuprous oxide nanoparticles selectively induce apoptosis of tumor cellsAssociation of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese populationAssociation of Fas -1377 G/A polymorphism with susceptibility to cancerNovel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation.Mitochondrial and postmitochondrial survival signaling in cancer.The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation.Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injurySynthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway.The Cdc42/Par6/aPKC polarity complex regulates apoptosis-induced compensatory proliferation in epithelia.Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesGamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells.hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processingDetection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells.Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysisTGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control studyAssociation of survivin polymorphisms with tumor susceptibility: a meta-analysisChaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cellsRNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cellsCASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.Impaired apoptosis and immune senescence - cause or effect?Diverse array-designed modes of combination therapies in Fangjiomics.The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potentialCytotoxic activity of genistein-8-C-glucoside form Lupinus luteus L. and genistein against human SK-OV-3 ovarian carcinoma cell line.Targeting apoptosis with dietary bioactive agents.Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancerDistinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye.Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways.Caspase polymorphisms and genetic susceptibility to multiple myelomaDNA damage-induced cell death: lessons from the central nervous system.Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma
P2860
Q24301847-626E31A7-A59E-4579-A1DC-0A6E44BD0C5FQ24681706-EB315681-8BCD-4AB3-9D25-A6744E3524FBQ27644353-3F33AB23-BB3C-4B2A-9E59-9687323C620CQ28385293-0D12A70B-95A4-4C23-B3A7-09180892C59BQ28392926-925F0D9A-D55E-407B-A8E0-845BA77B9715Q28396240-195FE882-6AB6-4D7A-B108-ABE8F6C648FEQ33222458-2B20A275-0E37-4380-85E1-85B70D208DEDQ33645577-9AD6B790-7F14-43D6-8686-4F002C818BA8Q33676854-45F8FA14-F252-44E4-91A4-98B754CF1AAAQ33694942-9B2FCA9C-8FD1-43CF-9E87-23DFE872C9F9Q33742019-4F7E2319-B0F1-4361-B911-1E068D8FFB52Q33855218-18B7DA18-6AFC-46BD-933B-0813736E76A7Q33855963-F08B40D3-3AA6-48EB-BA6E-E74191CF8EBAQ34021063-3058FAF3-4779-42D2-ABAA-A1E3DC7BD407Q34116302-7C738EE0-47B9-4F76-8CB7-2AF4ECB3E483Q34139691-E4C798D9-0792-43E4-B76A-1F19D0993BDAQ34169082-065BAC3D-0301-410C-814F-7266EBEE75D5Q34245430-1A45895F-3C6E-4E3E-919D-A1A423DE9DFAQ34447887-2A3BD483-6048-46F1-910E-29919606B7E6Q34553378-C8288DF8-1D6B-41AA-A9A4-52AF43804EB2Q34583884-AB45D614-723B-43E8-8D27-97DDDD3AA01CQ34639841-7B83BABA-9281-43C5-B745-31C18528E837Q34685905-8717F486-ED06-402C-89B1-6A8261A60F8DQ34863364-6714D930-42CC-47E7-B911-C17D67BCB269Q35009907-19A3BF58-1B52-4340-B529-73D073A03259Q35154556-C566F502-8888-42F2-A20E-8E854AF21DE7Q35630444-4B02E18A-23BA-4C6A-82FA-E58B1142F759Q35892035-12F57C1A-016F-4E90-926C-E615ECD5FA1FQ36121033-4837193D-666B-4886-B61F-CFC8581DED64Q36123974-8539B068-FED7-4C45-BBE8-AD32B4FA8AC1Q36174027-6EDC77F0-8875-48C3-94D7-C08F174A7231Q36256855-DAD5615B-1722-45A3-9488-3CA5E67C489EQ36381878-D0883716-4C3D-445E-8969-154A045ED820Q36483179-401DC85E-3506-40D4-AC38-106CF9C42495Q36514191-0206CD30-292D-4833-98DF-DABF196CF8D2Q36704112-F318088C-1AC5-4B09-B6F1-5331011FDB63Q36919048-9F8307F6-6E4D-4107-B036-150321911856Q36981342-373BA1CA-9A49-45EF-B44F-678DBB3BE69FQ37034919-324A96A0-F692-42D0-A5C4-D627B6469795Q37225266-613CB971-46BA-4346-9651-7568D104A2BE
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Apoptosome dysfunction in human cancer.
@ast
Apoptosome dysfunction in human cancer.
@en
type
label
Apoptosome dysfunction in human cancer.
@ast
Apoptosome dysfunction in human cancer.
@en
prefLabel
Apoptosome dysfunction in human cancer.
@ast
Apoptosome dysfunction in human cancer.
@en
P1433
P1476
Apoptosome dysfunction in human cancer.
@en
P304
P356
10.1023/B:APPT.0000045786.98031.1D
P577
2004-11-01T00:00:00Z
P6179
1020655404